Stanozolol and the Treatment of Severe Chronic Venous Insufficiency

Abstract

A report on an analysis of an open (pilot) study is given for evaluating the effectiveness of stanozolol in the treatment of chronic venous insufficiency (CVI). Twelve patients with CVI grade II–III according to Widmer were treated for 6 months with the modified anabolic steroid stanozolol. Evaluation of the influence of this drug on CVI was monitored with transcutaneous oxygen tension measurements (TcPo₂), light reflection rheography (LRR), histopathology and immunofluorescence techniques. After 3 and 6 months a statistically significant extension of the refilling time by LRR was observed. There is also a significant change in TcPo₂measurements at 3 months but not at 6 months. With immunofluorescence and peroxidase techniques, fibrinogen and collagen IV deposits are found in the majority of cases around the capillaries. It is postulated that these deposits play an important role in the pathogenesis of CVI. After treatment with stanozolol a significant reduction of the dermal space was observed in the lipodermatosclerotic plaque. It is concluded that in the treatment of CVI grade II–III stanozolol can be useful. A randomised double blind clinical trial is necessary to confirm this effectiveness.

Keywords

chronic venous insufficiency light reflection rheography transcutaneous oxygen measurements stanozolol fibrinogen collagen IV

Get full access to this article

View all access options for this article.

References

Widmer

L.K.

Stahelin

H.B.

Peripheral venous disorders; prevalence and socio-medical importance; observations in 4529 apparently healthy persons; Basle Study III, Bern: Hans Huber, 1978.

Browse

N.L.

Burnand

K.G.

The cause of venous ulceration. Lancet 1982; 2: 243–245.

Fagrell

Microcirculatory disturbances — The final cause for venous leg ulcers?

VASA 1982; 11: 101–103.

Neumann

H.A.M.

Leeuwen

M. v.

v. d. Broek

M.J. T. B.

Berretty

P.J.M.

Transcutaneous oxygen tension in chronic venous insufficiency syndrome. VASA 1984; 13: 213–219.

Browse

N.L.

Gray

Jarrett

P.E.M.

Morland

Blood and vein-wall fibrinolytic activity in health and vascular disease. Br Med J 1977; 1: 478–481.

Kluft

Preston

F.E.

Malia

R.G.

, Stanozolol induced changes in fibrinolysis and coagulation in healthy adults. Thromb Haemostas 1984; 51: 157–164.

Burnand

Clemenson

Morland

Jarrett

P.E.M.

Browse

N.L.

Venous lipodermatosclerosis: Treatment by fibrinolytic enhancement and elastic compression. Br Med J 1980 ;280: 7–11.

Huch

Albani

Gabriel

Schulte

FJ.

Wolf

Rupprath

Emmrich

Stechele

Duc

Bucher

Transcutaneous Po₂ monitoring in routine management of infants and children with cardio-respiratory problems. Pediatrics 1976; 57: 681–690.

Wienert

Blazek

Eine neue Methode zur unblutigen dynamischen Vene druckmessung. Der Hautartz 1982; 33: 498–499.

10.

Neumann

H.A.M.

Relevance of fluorescence techniques in immunological mediated skin disease. Dutch Efficiency Bureau, Amsterdam, 1983, Thesis.

11.

Ploem

J.S.

The use of a vertical illuminator with interchangeable dichroic mirrors for fluorescence microscopy with incident light. Z Wissensch Mikrosc 1967; 68: 129.

12.

NWA. Statpak, Multi-Function Statistics Library, Version 3.1; Northwest Analytical Inc. Portland Org. USA, 1984.

13.

v. d. Broek

M.J. T. B.

Neumann

H.A.M.

Evaluation of a new veno-active drug bencianol (ZY 15051). In Phlebology 85, ed. Negus

Jantet

, pp. 879–881, London: John Libbey.

14.

Neumann

H.A.M.

Mesure de la tension en oxygène transcutanée dans le syndrome d'insuffisance veineuse chronique. In Phlebologie 83, ed. Merlin

NJ.

, pp. 199–200, Bruxelles: Medical Media International Inc, 1984.

15.

Leu

H.J.

Wenner

Spycher

Brunner

Ultrastrukturelle Veränderungen bei Atrofie blanche. VASA 1980; 9: 142–146.

16.

Burnand

K.G.

Whimster

Naidoo

Browse

N.L.

Pericapillary fibrin in the ulcer-bearing skin of the leg: The cause of lipodermatosclerosis and venous ulceration. Br Med J 1982; 285: 1071–1072.

17.

Bollinger

Jäger

Geser

Sgier

Seglias

Transcapillary and interstitial diffusion of Na-fluorescein in chronic venous insufficiency with white atrophy. Int J Microcirc Clin Exp 1982; 1: 5–17

18.

Franzeck

U.K.

Bollinger

Huch

Transcutaneous oxygen tension, capillary morphology and density in patients with chronic venous incompetency (CVI). Circulation 1984; 70: 806–811.

19.

Haselbach

Vollenweide

Moneta

Bollinger

Microangiopathy in severe chronic venous insufficiency evaluated by flurescence video-microscopy. Phlebology 1986; 1: 159–169.

20.

Uitto

Ryhänen

Tan

E.M.L.

In Connective tissue disease, ed. Uitto

, pp. 103–117, Basel: Marcel Dekker, 1987.

21.

Westberg

M.G.

Biochemical alterations of the human glomerular basement membrane in diabetes. Diabetes 1976; 25: (Suppl. 2), 920–924.

22.

Westberg

M.G.

Michael

A.F.

Human glomerular basement membrane: Chemical composition in diabetes mellitus. Acta Med Scand 1973; 194: 39–47.

23.

Rohrbach

D.H.

Wagner

C.W.

Star

Martin

G.R.

Brown

K.S.

Yoon

J.W.

Reduced synthesis of basement membrane heparan sulfate proteoglycan in streptozotocin induced diabetic mice. J Biol Chem 1983; 258: 11672–11677.